Skip to main content

Blogs

Difficult to Treat Rheumatoid Arthritis

Dr. Cush addresses the management of difficult-to-treat rheumatoid arthritis (D2TRA).

Methotrexate

In this session, Dr. Jack Cush reviews methotrexate.

Rheumatoid & Inflammation Testing

Master the dos and don'ts of ordering RF, CCP (ACPA), and inflammatory markers that could transform your diagnostic accuracy.

Antinuclear Antibodies (ANA)

Dr. Jack Cush reviews autoantibody testing in rheumatology.

Evaluation of Rheumatic Complaints

Dr. Cush provides a systematic approach to evaluating musculoskeletal and rheumatic complaints in clinical practice.

CNS Lupus (NPSLE)

29 yr. old woman with SLE and transverse myelitis. Is this NPSLE; how to diagnose?

Hydroxychloroquine for Everyone

Nearly 25 years ago, while lecturing on best therapies for rheumatoid arthritis (RA), I loudly stated that hydroxychloroquine was “useless” and, deservedly, I was “boo-ed” off stage. My point then was that rheumatologists needed to be aggressive, if not overly aggressive, in treating all RA patients. And my view was that HCQ was representative of under-treatment. I have reconsidered the use of HCQ in RA substantially in the last few years, based on its merit.

From DNA to PGA

I have been investigating the mechanisms of antinuclear antibody (ANA) expression in SLE since 1978. In this pursuit, I have followed the advice of my first division chief, Dr. Ralph Snyderman, a great academician.  Ralph told me to identify a research focus and make it mine. I think I have done reasonably well in my mission so you can imagine my surprise (and excitement) when, for the Lupus 2025 meeting in Toronto, I was asked to conduct a Meet the Professor session on the Type 1 & 2 model for SLE.

The War Rheum

The effects on rheumatologists and their patients living in Ukraine largely have been unseen by the world. At ACR Convergence 2024, I met Dr. Marta Dzhus who practices at St. Michael's Clinical Hospital in Kyiv; she shared her story with me about the humanitarian crisis in rheumatologic care in Ukraine because of the ongoing war. Here is an excerpt of our conversation.

Rheum to Travel

One of the benefits of attending conferences aside from scientific exchange is meeting new people. At one symposium, I met a unique rheumatologist. This chance meeting turned into an interview, that turned into a blog. Holly Bastian, MD is a rheumatologist practicing without the restraints of being tied to a place. She is a nomadic rheumatologist, a rheum on the road who embodies Johnny Appleseed as she spreads her knowledge and skills to multiple places in need of rheumatologic services. This is her story.

Overlap Syndrome with ILD

How would you manage a patient with Overlap (anti-synthetase) syndrome, ILD, polyarthritis and myositis?

The EHR is Down! $@&#!

The advantage to patient care without the crutch of an EHR. What do you do?

×